AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $819,000 | -0.4% | 327,550 | +147.5% | 0.18% | +39.5% |
| Q1 2016 | $822,000 | -38.5% | 132,343 | -3.4% | 0.13% | -26.3% |
| Q4 2015 | $1,337,000 | +45.3% | 137,018 | +0.4% | 0.18% | +19.9% |
| Q3 2015 | $920,000 | -21.0% | 136,478 | +0.7% | 0.15% | +7.4% |
| Q2 2015 | $1,165,000 | -7.4% | 135,584 | -0.1% | 0.14% | -6.2% |
| Q1 2015 | $1,258,000 | – | 135,728 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 31,839,850 | $42,348,000 | 0.28% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $978,000 | 0.14% |
| INVESTOR AB | 3,510,189 | $4,669,000 | 0.14% |
| Tibra Equities Europe Ltd | 241,100 | $321,000 | 0.10% |
| FIRST MIDWEST BANK TRUST DIVISION | 349,158 | $464,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 372,543 | $495,000 | 0.06% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 110,000 | $146,000 | 0.04% |
| Kalos Management, Inc. | 19,250 | $24,000 | 0.01% |
| Summit Global Investments | 110,100 | $146,000 | 0.01% |
| Founders Capital Management | 10,000 | $13,000 | 0.01% |